Immunoglobulin M for acute infection: True or false?

Clinical and Vaccine Immunology

Volumn 23, Issue 7, 2016, Pages 540-545

  Landry, Marie Louise ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; EPSTEIN BARR VIRUS ANTIGEN 1; HETEROPHILE ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; SULFANILAMIDE DERIVATIVE; VIRUS CAPSID ANTIGEN;

ACUTE HEPATITIS A; ADENOVIRUS INFECTION; ADENOVIRUS PNEUMONIA; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFUSION; CONGESTIVE HEART FAILURE; CROSS REACTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DAY HOSPITAL; DELUSION; DIAGNOSTIC ACCURACY; DRUG HYPERSENSITIVITY; EPSTEIN BARR VIRUS; FALSE POSITIVE RESULT; FEMALE; FEVER; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; IMMUNODETECTION; IMMUNOFLUORESCENCE TEST; INTENSIVE CARE; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOPENIA; LUMBAR PUNCTURE; LUNG INFILTRATE; LYME DISEASE; MALE; MEASLES VIRUS; MENINGOENCEPHALITIS; MIDDLE AGED; NEUROIMAGING; NOSE SMEAR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REPEAT PROCEDURE; SERODIAGNOSIS; THORAX RADIOGRAPHY; VIROLOGY; VIRUS INFECTION; VIRUS MENINGITIS; VIRUS PNEUMONIA; WEST NILE VIRUS; BLOOD; COMMUNICABLE DISEASES; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEROLOGY;

COMMUNICABLE DISEASES; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84977647332     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00211-16     Document Type: Article

References (44)

1. Jorgensen JH, Pfaller MA, Carroll KC, Funke G, Landry ML, Richter SS, Warnock DW (ed). 2015. Manual of clinical microbiology, 11th ed. ASM Press, Washington, DC.
2. Bhatti AB, Ali F, Satti SA. 2015. Cross-reactivity of rapid Salmonella Typhi IgM immunoassay in dengue fever without co-existing infection. Cureus 7:e396.
3. Pancer KW. 2015. Cross-reactions in IgM ELISA tests to Legionella pneumophila sg1 and Bordetella pertussis among children suspected of legionellosis; potential impact of vaccination against pertussis? Cent Eur J Immunol 40:180-187.
4. Miyashita N, Akaike H, Teranishi H, Kawai Y, Ouchi K, Kato T, Hayashi T, Okimoto N; Atypical Pathogen Study Group. 2013. Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection. J Infect Chemother 19:256-260. http://dx.doi.org/10.1007/s10156-012-0494-4.
5. Kamata A, Obinata K, Niizuma T, Kinoshita K, Shimizu T. 2012. The validity of the criteria for primary infection of Chlamydophila pneumoniae in children by measuring ELISA IgM antibodies. J Infect Chemother 18:308-312. http://dx.doi.org/10.1007/s10156-011-0327-x.
6. Beal S, Racsa L, Alatoom A. 2014. Implications of false positive serology of Toxoplasma gondii in a pre-transplant patient. Lab Med 45:56-58. http://dx.doi.org/10.1309/LMQIB0BPOJ96WGCU.
7. Dhakal R, Gajurel K, Pomares C, Talucod J, Press CJ, Montoya JG. 2015. Significance of a positive toxoplasma immunoglobulinMtest result in the United States. J Clin Microbiol 53:3601-3605. http://dx.doi.org/10.1128/JCM.01663-15.
8. Uçkay I, Wunderli W, Giostra E, Majno P, Mentha G, van Delden, C. 2009. False serologic evidence for acute primary toxoplasmosis during liver transplantation for fulminant hepatitis B: A case report. Transplant Proc 41:4425- 4427. http://dx.doi.org/10.1016/j.transproceed.2009.09.081.
9. Kuberski T, Herrig J, Pappagianis D. 2010. False-positive IgM serology in coccidioidomycosis. J Clin Microbiol 48:2047-2049. http://dx.doi.org/10.1128/JCM.01843-09.
10. Seriburi V, Ndukwe N, Chang Z, Cox ME, Wormser GP. 2012. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect 18:1236-1240. http://dx.doi.org/10.1111/j.1469-0691.2011.03749.x.
11. Prince HE, Su X, Hogrefe WR. 2007. Utilization of hantavirus antibody results generated over a five-year period to develop an improved serologic algorithm for detecting acute Sin Nombre hantavirus infection. J Clin Lab Anal 21:7-13. http://dx.doi.org/10.1002/jcla.20145.
12. Prince HE, Lieberman JM. 2013. Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory. Clin Vaccine Immunol 20:1213-1216. http://dx.doi.org/10.1128/CVI.00326-13.
13. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage HM, Komar N, Panella NA, Allen BC, Volpe KE, Davis BS, Roehrig JT. 2000. Rapid detection of West Nile virus from human clinical specimens, fieldcollected mosquitoes, and avian samples by a TaqMan reverse transcriptase- PCR assay. J Clin Microbiol 38:4066-4071.
14. Prince HE, Calma J, Pham T, Seaton BL. 2009. Frequency of missed cases of probable acute West Nile virus (WNV) infection when testing forWNV RNA alone or WNV immunoglobulin M alone. Clin Vaccine Immunol 16:587-588. http://dx.doi.org/10.1128/CVI.00462-08.
15. Morjaria S, Arguello E, Taur Y, Sepkowitz K, Hatzoglou V, Nemade A, Rosenblum M, Cavalcanti MS, Palomba ML, Kaltsas A. 2015. West Nile virus central nervous system infection in patients treated With rituximab: implications for diagnosis and prognosis, with a review of literature. Open Forum Infect Dis 2:ofv136. http://dx.doi.org/10.1093/ofid/ofv136.
16. Hyams C, Mabayoje DA, Copping R, Maranao D, Patel M, Labbett W, Haque T, Webster DP. 2014. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol 86:478-483. http://dx.doi.org/10.1002/jmv.23827.
17. Post JJ, Chan MK, Whybin LR, Shi Q, Rawlinson WD, Cunningham P, Robertson PW. 2011. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol 83:1406-1409. http://dx.doi.org/10.1002/jmv.22109.
18. Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 56:186-191.
19. Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. 2003. Primary cytomegalovirus infection in an outpatient settinglaboratory markers and clinical aspects. Infection 31:318-323.
20. Ghinoiu M, Naveau S, Barri-Ova N, Thaury J, Grangeot-Keros L, Perlemuter G. 2009. Acute hepatitis E infection associated with a falsepositive serology against Epstein-Barr virus. Eur J Gastroenterol Hepatol 21:1433-1435. http://dx.doi.org/10.1097/MEG.0b013e32832f5be4.
21. Alatoom A, Ansari MQ, Cuthbert J. 2013. Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody. Arch Pathol Lab Med 137:90 -95. http://dx.doi.org/10.5858/arpa.2011-0693-OA.
22. Centers for Disease Control and Prevention. 2005. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis-United States, 2002-2004. MMWR Morb Mortal Wkly Rep 54:453-456.
23. Jang JH, Jung YM, Kim JS, Lee SH, Kim JW, Hwang SG, Rim KS, Park SJ, Park YM, Kang SK, Lee HS, Yun H, Kim JH, Jeong SH. 2011. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: A prospective, multicentre study in Korea. J Viral Hepat 18:e408 - e414. http://dx.doi.org/10.1111/j.1365-2893.2011.01477.x.
24. Kim HS, Jeong SH, Jang JH, Myung HJ, Kim JW, Bang SM, Song SH, Kim H, Yun HS. 2011. Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: A case report. Korean J Hepatol 17:323-327. http://dx.doi.org/10.3350/kjhep.2011.17.4.323.
25. Centers for Disease Control and Prevention. 2012. Notes from the field: false-positive measles test-Maine, February 2012. MMWR Morb Mortal Wkly Rep 61:396.
26. Jenkerson SA, Beller M, Middaugh JP, Erdman DD. 1995. False positive rubeola IgM tests. N Engl J Med 332:1103-1104.
27. Woods CR. 2013. False-positive results for immunoglobulin M serologic results: Explanations and examples. J Pediatric Infect Dis Soc 2:87-90. http://dx.doi.org/10.1093/jpids/pis133.
28. Costa E, Tormo N, Clari MA, Bravo D, Munoz-Cobo B, Navarro D. 2009. Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulinMassays on the liaison platform with sera from patients displaying acute parvovirus B19 infection. Clin Vaccine Immunol 16: 1247-1248. http://dx.doi.org/10.1128/CVI.00142-09.
29. Kinno R, Kurokawa S, Uchiyama M, Sakae Y, Kasai H, Ogata H, Kinugasa E. 2015. False-positive results obtained for immunoglobulin M antibody tests of cerebrospinal fluid for herpes simplex virus in a patient with varicella zoster virus encephalitis. Intern Med 54:2667-2670. http://dx.doi.org/10.2169/internalmedicine.54.4891.
30. Prince HE, Lape'-Nixon M, Moore RJ, Hogrefe WR. 2004. Utility of the focus technologies West Nile virus immunoglobulin M capture enzymelinked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol 42:12-15. http://dx.doi.org/10.1128/JCM.42.1.12-15.2004.
31. Centers for Disease Control and Prevention. 2009. False-positive results with a commercially available West Nile virus immunoglobulin m assay- United States, 2008. MMWR Morb Mortal Wkly Rep 58:458-460.
32. Centers for Disease Control and Prevention. 2011. Human Jamestown canyon virus infection-Montana, 2009. MMWR Morb Mortal Wkly Rep 60:652-655.
33. Sakiani S, Koh C, Heller T. 2014. Understanding the presence of falsepositive antibodies in acute hepatitis. J Infect Dis 210:1886-1889. http://dx.doi.org/10.1093/infdis/jiu348.
34. Navalpotro D, Gimeno C, Navarro D. 2006. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection. J Med Virol 78:1449-1451. http://dx.doi.org/10.1002/jmv.20715.
35. Kurtz JB, Anderson MJ. 1985. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet ii:1356.
36. Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA. 2000. The West Nile virus outbreak of 1999 in New York: The Flushing Hospital experience. Clin Infect Dis 30:413- 418. http://dx.doi.org/10.1086/313737.
37. Oduyebo T, Petersen EE, Rasmussen SA, Mead PS, Meaney-Delman D, Renquist CM, Ellington SR, Fischer M, Staples JE, Powers AM, Villanueva J, Galang RR, Dieke A, Munoz JL, Honein MA, Jamieson DJ. 2016. Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure- United States, 2016. MMWR Morb Mortal Wkly Rep 65:122-127. http://dx.doi.org/10.15585/mmwr.mm6505e2.
38. Vorou R. 2016. Letter to the editor: diagnostic challenges to be considered regarding Zika virus in the context of the presence of the vector Aedes albopictus in Europe. Euro Surveill 21(10). http://dx.doi.org/10.2807/1560-7917.ES.2016.21.10.30161.
39. Prince HE, Lape-Nixon M. 2014. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol 21:1377-1384. http://dx.doi.org/10.1128/CVI.00487-14.
40. Meurman OH, Ziola BR. 1978. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol 31:483-487. http://dx.doi.org/10.1136/jcp.31.5.483.
41. MacKenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G, Zarvan BS. 1992. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 268:1015-1017.
42. Tennant E, Post JJ. 2016. Production of false-positive immunoglobulin Mantibodies to hepatitis A virus in autoimmune events. J Infect Dis 213: 324-325. http://dx.doi.org/10.1093/infdis/jiv417.
43. Bartels EM, Ribel-Madsen S. 2013. Cytokine measurements and possible interference from heterophilic antibodies-problems and solutions experienced with rheumatoid factor. Methods 61:18-22. http://dx.doi.org/10.1016/j.ymeth.2012.12.015.
44. Chen T, Hedman L, Mattila PS, Jartti L, Jartti T, Ruuskanen O, Soderlund-Venermo M, Hedman K. 2012. Biotin IgM antibodies in human blood: A previously unknown factor eliciting false results in biotinylation- based immunoassays. PLoS One 7:e42376. http://dx.doi.org/10.1371/journal.pone.0042376.